Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway

被引:20
|
作者
Giatromanolaki, Alexandra [1 ,2 ,3 ]
Koukourakis, Michael I. [1 ,2 ,3 ]
Pezzella, Francesco [4 ,5 ]
Turley, Helen [4 ,5 ]
Sivridis, Efthimlos [1 ,2 ,3 ]
Bouros, Demosthenes [1 ,2 ,3 ]
Bougioukas, George [1 ,2 ,3 ]
Harris, Adrian L. [4 ,5 ]
Gatter, Kevin C. [4 ,5 ]
机构
[1] Democritus Univ Thrace, Dept Pathol, Alexandroupolis 68100, Greece
[2] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis 68100, Greece
[3] Democritus Univ Thrace, Dept Pneumol & Thorac Surg, Alexandroupolis 68100, Greece
[4] John Radcliffe Hosp, Canc Res UK Mol Oncol Lab, Inst Mol Med, Oxford OX3 9DU, England
[5] Univ Oxford, Nuffield Dept, Clin Sci Lab, Oxford OX3 9DU, England
关键词
lung cancer; hypoxia inducible factors; prolyl-hydroxylases; asparagine hydroxylases; lactate dehydrogenase;
D O I
10.1016/j.canlet.2007.11.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The oxygen sensitive prolyl-hydroxylase domain enzymes (PHDs) and the asparagines hydroxylase (FIH, factor inhibiting HIF) regulate the transcriptional activity of HIFs. We assessed the expression of these enzymes in a series of 73 non-small cell lung carcinomas (NSCLC). A direct association of PHDs with FIH and of the PHDs/FIH with HIFs expression was noted. Thirty three of 73 cases had high HIF/PHD expression, predicting intense HIF activity; 19/73 cases had low H IF and high PHD expression mimicking the normal bronchial pattern-, and 18/73 cases had low HIF/PHD (inactive HIF pathway). High lactate dehydrogenase LDH5 expression was noted in cases with high HIF/PHD phenotype. The value of such a classification in defining different metabolic phenotypes of NSCLC deserves further evaluation. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 50 条
  • [21] Expression and Clinical Implication of HIF-1α and VEGF-C in Non-small Cell Lung Cancer
    左顺庆
    季艳梅
    王建军
    郭家龙
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2008, (06) : 674 - 676
  • [22] Expression and Clinical Implication of HIF-1α and VEGF-C in Non-small Cell Lung Cancer
    Zuo, Shunqing
    Ji, Yanmei
    Wang, Jianjun
    Guo, Jialong
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2008, 28 (06) : 674 - 676
  • [23] Expression and clinical implication of HIF-1α and VEGF-C in non-small cell lung cancer
    Shunqing Zuo
    Yanmei Ji
    Jianjun Wang
    Jialong Guo
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2008, 28 : 674 - 676
  • [24] Hypoxia inducible factor (HIF)-1α in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Jones, JL
    Cox, G
    Richardson, C
    Richardson, D
    Allen, C
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S28 - S28
  • [25] IMP3 expression in non-small, cell lung cancer
    Bellezza, Guido
    Cavaliere, Antonio
    Sidoni, Angelo
    HUMAN PATHOLOGY, 2009, 40 (08) : 1205 - 1206
  • [26] TROP2 expression in non-small cell lung cancer
    Kuo, Peiwen
    Elboudwarej, Emon
    Diehl, Lauri
    Patel, Jilpa
    Mekan, Sabeen
    Jurgensmeier, Juliane M.
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Aberrant expression of HIF3A in plasma of patients with non-small cell lung cancer and its clinical significance
    Wei, Liang
    Yuan, Na
    Chen, Yingying
    Gong, Pingping
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (08)
  • [28] Expression of apoptosome pathway-related transcripts in non-small cell lung cancer
    Evžen Křepela
    Jan Procházka
    Pavel Fiala
    Petr Zatloukal
    Pavel Selinger
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 57 - 68
  • [29] Expression of apoptosome pathway-related transcripts in non-small cell lung cancer
    Krepela, E
    Procházka, J
    Fiala, P
    Zatloukal, P
    Selinger, P
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (01) : 57 - 68
  • [30] Immunohistochemical Expression and Prognostic Value of VEGF, HIF-1 alpha, EGFR in Non-Small Cell Lung Cancer
    Kim, Myung Sook
    Park, Sung Hak
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2010, 68 (01) : 22 - 28